FTC Releases Second Interim Staff Report on Prescription Drug …
3 days ago · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty generic drugs, including significant price markups by PBMs for cancer, HIV, and a variety of other critical drugs.
Pharmacy Benefit Managers: The Powerful Middlemen Inflating …
Jul 9, 2024 · Lina M. Khan was sworn in as Chair of the Federal Trade Commission on June 15, 2021.
US FTC finds major pharmacy benefit managers inflated drug …
3 days ago · A U.S. flag flutters at the Federal Trade Commission (FTC) headquarters in Washington, D.C., U.S., November 24, 2024. REUTERS/Benoit Tessier/File Photo Purchase Licensing Rights, opens new tab
PBMs made billions marking up specialty drugs by more than …
3 days ago · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
Jul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating...
FTC finds middlemen inflate specialty generic drug prices by
3 days ago · Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
Nov 20, 2023 · overview of PBMs’ key functions, selected federal and state laws that regulate these entities, and issues surrounding federal preemption of state laws addressing PBMs. Federal Trade Commission (FTC)
Pharmacy benefit managers profit at expense of patients and small ... - CNN
Jul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC releases second report slamming pharmacy benefit managers
4 days ago · The building of the Federal Trade Commission in downtown Washington D.C. The FTC has released its second report digging into how the business practices of pharmacy benefit managers could be ...
US pharmacy groups marked up drug prices for $7.3bn gain, …
3 days ago · Several of the biggest US pharmacy benefit managers have generated more than $7.3bn in revenue by charging “enormous mark-ups” for drugs treating cancer and HIV, according to the US Federal ...